Immunohistochemical Evaluation of Lymph Node Micrometastases from Breast Cancer

References

• Fisher B., Slack N., Katrych D., Wolmark N. Ten-year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 1975; 140: 528–34
   PubMedGoogle Scholar
• Schottenfeld D., Nash A. G., Robbins G. F., Beattie EJ, Jr. Ten-year results of the treatment of primary operable breast carcinoma. Cancer 1976; 38: 1001–7
   PubMed Web of Science ®Google Scholar
• Breast Cancer Study Group. Identification of breast cancer patients with high risk of early recurrence after radical mastectomy. Cancer 1978; 42: 2809–26
   PubMedGoogle Scholar
• Fisher E. R., Swamidoss B., Lee C. H., Rockette H., Redmond C., Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978; 42: 2025–31
   PubMed Web of Science ®Google Scholar
• Rosen P. P., Saigo P. E., Braun D. W., Weathers E., Fracchia A. A., Kinne D. W. Axillary micro- and macrometastases in breast cancer: Prognostic significance of tumor size. Ann Surg 1981; 194: 585–91
   PubMed Web of Science ®Google Scholar
• McGuire W. L., Abeloff M. D., Fisher B., Glick J. H., Henderson I. C., Osborne C. K. Adjuvant therapy in node-negative breast cancer. Breast Cancer Res Treat 1989; 13: 97–115
   PubMedGoogle Scholar
• De Mascarel I., Bonichon F., Coindre J. M., Trojani M. Prognostic significance of breast cancer axillary lymph nodes micrometastases assessed by two special techniques: reevaluation with longer follow up. Br J Cancer 1992; 66: 523–7
   PubMed Web of Science ®Google Scholar
• Wells C. A., Heryet A., Brochier J., Gatter K. C., Mason D. Y. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984; 50: 193–7
   PubMed Web of Science ®Google Scholar
• Bussolati G., Gugliotta P., Morra I., Pietribiasi F., Berardengo E. The imrnunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 1986; 54: 631–6
   PubMed Web of Science ®Google Scholar
• Trojani M., de Mascarel I., Bonichon F., Coindre J. M., Delsol G. Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance. Br J Cancer 1987; 55: 303–6
   PubMed Web of Science ®Google Scholar
• Berry N., Jones D. B., Marshall R., Smallwood J., Taylor I. Comparison of the detection of breast metastases by routine histological diagnosis and by imrnunohistochemical staining. Eur Surg Res 1988; 20: 225–32
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
   PubMed Web of Science ®Google Scholar
• Saccani Jotti G., Grassi C., Fontanesi M., Becchi G., Tardini A. Demonstration of mucinous-like carcinoma-associated antigen in bone marrow and lymph node biopsies from patients with breast carcinoma. Int J Biol Markers 1991; 6: 167–72
   PubMedGoogle Scholar
• Byrne J., Waldron R., McAvinchey D., Dervan P. The use of monoclonal antibodies for the histological detection of mammary axillary micrometastases. Eur J Surg Oncol 1987; 13: 409–11
   PubMedGoogle Scholar
• Pickren J. W. Significance of occult metastases: A study of breast cancer. Cancer 1961; 14: 1266–71
   PubMed Web of Science ®Google Scholar
• International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary node metastases from breast cancer. Lancet 1990; 335: 1565–8
   PubMed Web of Science ®Google Scholar
• Neville A. M. Are breast cancer micrometastases worth detecting. J Pathol 1990; 161: 283–4
   PubMed Web of Science ®Google Scholar
• Sloane J. P., Ormerod M. G., Imrie S. F., Coombes R. C. The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections. Br J Cancer 1980; 42: 392–8
   PubMed Web of Science ®Google Scholar
• Delsol F., Stein H., Pulford K. A. F., et al. Human lymphoid cells express epithelial membrane antigen: Implications for diagnosis of human neoplasm. Lancet 1984; 2: 1124–8
   PubMed Web of Science ®Google Scholar
• Zenklusen H. R., Stahli C., Gudat F., Overbeck J. V., Rolink J., Heitz P. U. The immunohistochemical reactivity of a new anti-epitheliaJ monoclonal antibody (Mab-b12) against breast carcinoma and other normal and neo-plastic human tissues. Virchow Arch A Pathol Anat 1988; 413: 3–10
   Google Scholar
• Byrne J., Horgan P. G., England S., Callaghan J., Given H. F. An evaluation of the usefulness of primary tumour expression of MCA and CA15–3 as prognostic indicators in breast carcinoma. Eur J Surg Oncol 1992; 18: 230–4
   PubMedGoogle Scholar
• Schoenfeld A., Luqmani Y., Smith D., et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994; 54: 2986–90
   PubMed Web of Science ®Google Scholar
• Noguchi S., Aihara T., Nakamori S., et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994; 74: 1595–600
   PubMed Web of Science ®Google Scholar
• Koyama H., Asaishi K., Yoshixnoto K., et al. Recurrence of node negative breast cancer. Jpn J Breast Cancer 1987; 4: 69–75, (in Japanese with English abstract).
   Google Scholar
• Sakamoto G., Sugano H., Hartmann W. H. Comparative pathological study of breast carcinoma among American and Japanese women. Breast Cancer, Vol 4, W. L. McGuire. Plenum Publishing Corporation, New York, London 1981; 211–31
   Google Scholar
• Fisher E. R., Palekar A., Rockette H., Redmond C., Fisher B. Pathologic findings from the national surgical adjuvant breast project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer 1978; 42: 2032–8
   PubMed Web of Science ®Google Scholar